THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis
Europe - FRA:TN8 - US8835561023 - Common Stock
470.35 EUR
+8 (+1.73%)
TN8 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 21 industry peers in the Life Sciences Tools & Services industry. While TN8 belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. TN8 is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year TN8 was profitable.
In the past year TN8 had a positive cash flow from operations.
TN8 had positive earnings in each of the past 5 years.
In the past 5 years TN8 always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of TN8 (6.50%) is better than 80.95% of its industry peers.
TN8's Return On Equity of 13.04% is fine compared to the rest of the industry. TN8 outperforms 76.19% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.25%, TN8 is in line with its industry, outperforming 52.38% of the companies in the same industry.
TN8 had an Average Return On Invested Capital over the past 3 years of 6.66%. This is in line with the industry average of 7.48%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.5% | ||
| ROE | 13.04% | ||
| ROIC | 6.25% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
1.3 Margins
Looking at the Profit Margin, with a value of 15.24%, TN8 belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
TN8's Profit Margin has been stable in the last couple of years.
TN8's Operating Margin of 18.18% is fine compared to the rest of the industry. TN8 outperforms 61.90% of its industry peers.
TN8's Operating Margin has improved in the last couple of years.
The Gross Margin of TN8 (41.34%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TN8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.18% | ||
| PM (TTM) | 15.24% | ||
| GM | 41.34% |
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TN8 is destroying value.
The number of shares outstanding for TN8 has been reduced compared to 1 year ago.
The number of shares outstanding for TN8 has been reduced compared to 5 years ago.
Compared to 1 year ago, TN8 has an improved debt to assets ratio.
2.2 Solvency
TN8 has a debt to FCF ratio of 5.71. This is a neutral value as TN8 would need 5.71 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.71, TN8 is in line with its industry, outperforming 57.14% of the companies in the same industry.
TN8 has a Debt/Equity ratio of 0.65. This is a neutral value indicating TN8 is somewhat dependend on debt financing.
TN8's Debt to Equity ratio of 0.65 is on the low side compared to the rest of the industry. TN8 is outperformed by 61.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.71 | ||
| Altman-Z | N/A |
ROIC/WACC0.62
WACC10.09%
2.3 Liquidity
TN8 has a Current Ratio of 1.93. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
TN8's Current ratio of 1.93 is amongst the best of the industry. TN8 outperforms 85.71% of its industry peers.
TN8 has a Quick Ratio of 1.50. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.50, TN8 belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.23% over the past year.
The Earnings Per Share has been growing by 12.12% on average over the past years. This is quite good.
The Revenue has been growing slightly by 2.05% in the past year.
TN8 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.92% yearly.
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%
3.2 Future
The Earnings Per Share is expected to grow by 9.78% on average over the next years. This is quite good.
Based on estimates for the next years, TN8 will show a small growth in Revenue. The Revenue will grow by 4.62% on average per year.
EPS Next Y4.02%
EPS Next 2Y6.1%
EPS Next 3Y7.53%
EPS Next 5Y9.78%
Revenue Next Year2.76%
Revenue Next 2Y3.79%
Revenue Next 3Y4.46%
Revenue Next 5Y4.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 25.05, which means the current valuation is very expensive for TN8.
The rest of the industry has a similar Price/Earnings ratio as TN8.
Compared to an average S&P500 Price/Earnings ratio of 27.69, TN8 is valued at the same level.
Based on the Price/Forward Earnings ratio of 22.28, the valuation of TN8 can be described as rather expensive.
TN8's Price/Forward Earnings is on the same level as the industry average.
TN8 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.05 | ||
| Fwd PE | 22.28 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TN8 is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
TN8's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.55 | ||
| EV/EBITDA | 21.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TN8 does not grow enough to justify the current Price/Earnings ratio.
TN8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.23
PEG (5Y)2.07
EPS Next 2Y6.1%
EPS Next 3Y7.53%
5. Dividend
5.1 Amount
TN8 has a yearly dividend return of 0.32%, which is pretty low.
Compared to an average industry Dividend Yield of 0.69, TN8 is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.34, TN8's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
5.2 History
The dividend of TN8 is nicely growing with an annual growth rate of 15.37%!
Dividend Growth(5Y)15.37%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
9.26% of the earnings are spent on dividend by TN8. This is a low number and sustainable payout ratio.
TN8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.26%
EPS Next 2Y6.1%
EPS Next 3Y7.53%
FRA:TN8 (10/20/2025, 7:00:00 PM)
470.35
+8 (+1.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.65%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap177.61B
Analysts81.76
Price Target483.4 (2.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
Yearly Dividend1.3
Dividend Growth(5Y)15.37%
DP9.26%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.77%
Min EPS beat(2)-0.07%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)0.72%
Min EPS beat(4)-0.34%
Max EPS beat(4)1.69%
EPS beat(8)5
Avg EPS beat(8)1.74%
EPS beat(12)7
Avg EPS beat(12)1.2%
EPS beat(16)11
Avg EPS beat(16)5.31%
Revenue beat(2)2
Avg Revenue beat(2)0.45%
Min Revenue beat(2)0.28%
Max Revenue beat(2)0.62%
Revenue beat(4)3
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.62%
Revenue beat(8)5
Avg Revenue beat(8)-0.15%
Revenue beat(12)7
Avg Revenue beat(12)0.84%
Revenue beat(16)11
Avg Revenue beat(16)3.32%
PT rev (1m)1.76%
PT rev (3m)-1.86%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)-0.44%
EPS NY rev (1m)0.04%
EPS NY rev (3m)0.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.47%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.05 | ||
| Fwd PE | 22.28 | ||
| P/S | 4.79 | ||
| P/FCF | 33.55 | ||
| P/OCF | 27.32 | ||
| P/B | 4.1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.81 |
EPS(TTM)18.78
EY3.99%
EPS(NY)21.11
Fwd EY4.49%
FCF(TTM)14.02
FCFY2.98%
OCF(TTM)17.22
OCFY3.66%
SpS98.19
BVpS114.69
TBVpS-27.09
PEG (NY)6.23
PEG (5Y)2.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.5% | ||
| ROE | 13.04% | ||
| ROCE | 8.88% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 28.04% | ||
| OM | 18.18% | ||
| PM (TTM) | 15.24% | ||
| GM | 41.34% | ||
| FCFM | 14.28% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexcg growth 3Y-8.22%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
F-Score7
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.71 | ||
| Debt/EBITDA | 3.08 | ||
| Cap/Depr | 49.03% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 70.63% | ||
| Profit Quality | 93.71% | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | N/A |
F-Score7
WACC10.09%
ROIC/WACC0.62
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
EPS Next Y4.02%
EPS Next 2Y6.1%
EPS Next 3Y7.53%
EPS Next 5Y9.78%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%
Revenue Next Year2.76%
Revenue Next 2Y3.79%
Revenue Next 3Y4.46%
Revenue Next 5Y4.62%
EBIT growth 1Y5.17%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year13.53%
EBIT Next 3Y9.14%
EBIT Next 5Y8.68%
FCF growth 1Y5.4%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-1.49%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%